Apple procyanidins decrease cholesterol esterification and lipoprotein secretion in Caco-2/TC7 enterocytes

Journal of Lipid Research

Volumn 46, Issue 2, 2005, Pages 258-268

  Vidal, Romain ^a   Hernandez Vallejo, Sandra ^a   Pauquai, Thomas ^a   Texier, Odile ^b   Rousset, Monique ^a   Chambaz, Jean ^a   Demignot, Sylvie ^a   Lacorte, Jean Marc ^a  

^a INSERM   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Apolipoprotein B; Dietary lipids; Intestine; Polyphenol

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; POLYPHENOL; PROCYANIDIN DERIVATIVE; TRIACYLGLYCEROL;

APPLE; ARTICLE; CELL STRAIN CACO 2; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; DOSE RESPONSE; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOLIPEMIA; IN VIVO STUDY; INTESTINE CELL; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; MICELLE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; WINE;

APOLIPOPROTEINS B; BIFLAVONOIDS; BLOTTING, WESTERN; CACO-2 CELLS; CATECHIN; CELL LINE; CHOLESTEROL; CHOLESTEROL ESTERS; DNA PRIMERS; ENTEROCYTES; ESTERIFICATION; FLAVONOIDS; HUMANS; IMMUNOPRECIPITATION; KINETICS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS; LIVER; MALUS; MICELLES; PHENOLS; POSTPRANDIAL PERIOD; PROANTHOCYANIDINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS; TRIGLYCERIDES;

EID: 13944258412     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400209-JLR200     Document Type: Article

References (56)

1. Ness, A. R., and J. W. Powles. 1997. Fruit and vegetables, and cardiovascular disease: a review. Int. J. Epidemiol. 26: 1-13.
2. Hu, F. B., and W. C. Willett. 2002. Optimal diets for prevention of coronary heart disease. J. Am. Med. Assoc. 288: 2569-2578.
3. Bazzano, L. A., M. K. Serdula, and S. Liu. 2003. Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr. Atheroscler: Rep. 5: 492-499.
4. Scalbert, A., and G. Williamson. 2000. Dietary intake and bioavailability of polyphenols. J. Nutr. 130 (Suppl.): 2073-2085.
5. Frankel, E. N., J. Kanner, J. B. German, E. Parks, and J. E. Kinsella. 1993. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341: 454-457.
6. Gryglewski, R. J., R. Korbut, J. Robak, and J. Swies. 1987. On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 36: 317-322.
7. Stein, J. H., J. G. Keevil, D. A. Wiebe, S. Aeschlimann, and J. D. Folts. 1999. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 100: 1050-1055.
8. Theriault, A., Q. Wang, S. C. Van Iderstine, B. Chen, A. A. Franke, and K. Adeli. 2000. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid. J. Lipid Res. 41: 1969-1979.
9. Wilcox, L. J., N. M. Borradaile, L. E. de Dreu, and M. W. Huff. 2001. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J. Lipid Res. 42: 725-734.
10. Borradaile, N. M., L. E. de Dreu, L. J. Wilcox, J. Y. Edwards, and M. W. Huff. 2002. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem. J. 366: 531-539.
11. Davidson, N. O., and G. S. Shelness. 2000. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu. Rev. Nutr. 20: 169-193.
12. Hussain, M. M., J. Shi, and P. Dreizen. 2003. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J. Lipid Res. 44: 22-32.
13. Hernell, O., J. E. Staggers, and M. C. Carey. 1990. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. II. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry. 29: 2041-2056.
14. Rudel, L. L., R. G. Lee, and T. L. Cockman. 2001. Acyl coenzyme A:cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr. Opin. Lipidol. 12: 121-127.
15. Hyson, D., J. C. Rutledge, and L. Berglund. 2003. Postprandial lipemia and cardiovascular disease. Curr. Atheroscler. Rep. 5: 437-444.
16. de Koning, E. J., and T. J. Rabelink. 2002. Endothelial function in the post-prandial state. Atheroscler. Suppl. 3: 11-16.
17. Mee, K. A., and D. L. Gee. 1997. Apple fiber and gum arabic lowers total and low-density lipoprotein cholesterol levels in men with mild hypercholesterolemia. J. Am. Diet. Assoc. 97: 422-424.
18. Hayek, T., B. Fuhrman, J. Vaya, M. Rosenblat, P. Belinky, R. Coleman, A. Elis, and M. Aviram. 1997. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17: 2744-2752.
19. Aprikian, O., V. Duclos, S. Guyot, C. Besson, C. Manach, A. Bernalier, C. Morand, C. Remesy, and C. Demigne. 2003. Apple pectin and a polyphenol-rich apple concentrate are more effective together than separately on cecal fermentations and plasma lipids in rats. J. Nutr. 133: 1860-1865.
20. Chantret, I., A. Rodolosse, A. Barbat, E. Dussaulx, E. Brot-Laroche, A. Zweibaum, and M. Rousset. 1994. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J. Cell Sci. 107: 213-225.
21. Morel, E., S. Demignot, D. Chateau, J. Chambaz, M. Rousset, and F. Delers. 2004. Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes. Mol. Biol. Cell. 15: 132-141.
22. Boisfer, E., G. Lambert, V. Atger, N. Q. Tran, D. Pastier, C. Benetollo, J. F. Trottier, I. Beaucamps, M. Antonucci, M. Laplaud, S. Griglio, J. Chambaz, and A. D. Kalopissis. 1999. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis. J. Biol. Chem. 274: 11564-11572.
23. Chateau, D., T. Pauquai, F. Delers, M. Rousset, J. Chambaz, and S. Demignot. 2005. Lipid micelles stimulate the secretion of triglyceride-enriched apolipoprotein B48-containing lipoproteins by Caco-2 cells. J. Cell Physiol. 202: 767-776.
24. Sparks, J. D., and C. E. Sparks. 1990. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J. Biol. Chem. 265: 8854-8862.
25. Fisher, E. A., M. Pan, X. Chen, X. Wu, H. Wang, H. Jamil, J. D. Sparks, and K. J. Williams. 2001. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 276: 27855-27863.
26. Hussain, M. M. 2000. A proposed model for the assembly of chylomicrons. Atherosclerosis. 148: 1-15.
27. Casaschi, A., Q. Wang, K. Dang, A. Richards, and A. Theriault. 2002. Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase. Lipids. 37: 647-652.
28. Kam, N. T., E. Albright, S. N. Mathur, and F. J. Field. 1989. Inhibition of acylcoenzyme A:cholesterol acyltransferase activity in CaCo-2 cells results in intracellular triglyceride accumulation. J. Lipid Res. 30: 371-377.
29. Pal, S., E. Allister, A. Thomson, and J. C. Mamo. 2002. Cholesterol esters regulate apoB48 secretion in CaCo2 cells. Atherosclerosis. 161: 55-63.
30. Marzetta, C. A., Y. E. Savoy, A. M. Freeman, C. A. Long, J. L. Pettini, R. E. Hagar, P. B. Inskeep, K. Davis, A. F. Stucchi, R. J. Nicolosi and E. S. Hamanaka. 1994. Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys. J. Lipid Res. 35: 1829-1838.
31. Yugarani, T., B. K. Tan, M. Teh, and N. P. Das. 1992. Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids. 27: 181-186.
32. Kirk, E. A., P. Sutherland, S. A. Wang, A. Chait, and R. C. LeBoeuf. 1998. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J. Nutr. 128: 954-959.
33. Gorinstein, S., E. Bartnikowska, G. Kulasek, M. Zemser, and S. Trakhtenberg. 1998. Dietary persimmon improves lipid metabolism in rats fed diets containing cholesterol. J. Nutr. 128: 2023-2027.
34. Borradaile, N. M., K. K. Carroll, and E. M. Kurowska. 1999. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids. 34: 591-598.
35. Pal, S., N. Ho, C. Santos, P. Dubois, J. Mamo, K. Croft, and E. Allister. 2003. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of apoB100 from human HepG2 cells. J. Nutr. 133: 700-706.
36. Chang, T. Y., C. C. Chang, S. Lin, C. Yu, B. L. Li, and A. Miyazaki. 2001. Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr. Opin. Lipidol. 12: 289-296.
37. Olofsson, S. O., L. Asp, and J. Boren. 1999. The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr. Opin. Lipidol. 10: 341-346.
38. Liao, W., and L. Chan. 2000. Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells. J. Biol. Chem. 275: 3950-3956.
39. Sparks, J. D., R. Zolfaghari, C. E. Sparks, H. C. Smith, and E. A. Fisher. 1992. Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats. J. Clin. Invest. 89: 1418-1430.
40. Adeli, K., and A. Theriault. 1992. Insulin modulation of human apolipoprotein B mRNA translation: studies in an in vitro cell-free system from HepG2 cells. Biochem. Cell Biol. 70: 1301-1312.
41. Mitchell, D. M., M. Zhou, R. Pariyarath, H. Wang, J. D. Aitchison, H. N. Ginsberg, and E. A. Fisher. 1998. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence. Proc. Natl. Acad. Sci. USA. 95: 14733-14738.
42. Pariyarath, R., H. Wang, J. D. Aitchison, H. N. Ginsberg, W. J. Welch, A. E. Johnson, and E. A. Fisher. 2001. Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome. J. Biol. Chem. 276: 541-550.
43. Wilcox, L. J., P. H. Barren, R. S. Newton, and M. W. Huff. 1999. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of apoB. Arterioscler. Thromb. Vasc. Biol. 19: 939-949.
44. Gibbons, G. F., K. Islam, and R. J. Pease. 2000. Mobilisation of triacylglycerol stores. Biochim. Biophys. Acta. 1483: 37-57.
45. Gilham, D., S. Ho, M. Rasouli, P. Martres, D. E. Vance, and R. Lehner. 2003. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion. FASEB J. 17: 1685-1687.
46. Higashi, Y, H. Itabe, H. Fukase, M. Mori, Y. Fujimoto, and T. Takano. 2003. Transmembrane lipid transfer is crucial for providing neutral lipids during very low density lipoprotein assembly in endoplasmic reticulum. J. Biol. Chem. 278: 21450-21458.
47. Moini, H., G. Rimbach, and L. Packer. 2000. Molecular aspects of procyanidin biological activity: disease preventative and therapeutic potentials. Drug Metab. Drug Interact. 17: 237-259.
48. Spencer, J. P., H. Schroeter, B. Shenoy, S. K. Srai, E. S. Debnam, and C. Rice-Evans. 2001. Epicatechin is the primary bioavailable form of the procyanidin dimers B2 and B5 after transfer across the small intestine. Biochem. Biophys. Res. Commun. 285: 588-593.
49. Mackenzie, G. G., F. Carrasquedo, J. M. Delfino, C. L. Keen, C. G. Fraga, and P. I. Oteiza. 2004. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J. 18: 167-169.
50. Eng, E. T., J. Ye, D. Williams, S. Phung, R. E. Moore, M. K. Young, U. Gruntmanis, G. Braunstein, and S. Chen. 2003. Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res. 63: 8516-8522.
51. Fitzpatrick, D. F., B. Bing, D. A. Maggi, R. C. Fleming, and R. M. O'Malley. 2002. Vasodilating procyanidins derived from grape seeds. Ann. NY Acad. Sci. 957: 78-89.
52. Aldini, G., M. Carini, A. Piccoli, G. Rossoni, and R. M. Facino. 2003. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection. Life Sci. 73: 2883-2898.
53. Parhofer, K. G., E. Laubach, and P. H. Barrett. 2003. Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients. J. Lipid Res. 44: 1192-1198.
54. van Heek, M., C. Parley, D. S. Compton, L. Hoos, and H. R. Davis. 2001. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br. J. Pharmacol 134: 409-417.
55. de Jong, A., J. Plat, and R. P. Mensink. 2003. Metabolic effects of plant sterols and stanols (Review). J. Nutr. Biochem. 14: 362-369.
56. Delsing, D. J., E. H. Offerman, W. van Duyvenvoorde, H. van Der Boom, E. C. de Wit, M. J. Gijbels, A. van Der Laarse, J. W. Jukema, L. M. Havekes, and H. M. Princen. 2001. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. Circulation. 103: 1778-1786.